mirvetuximab
immunogen
['4147', 'mirvetuximab', 'immunogen']
we re here, #asco22! find us this weekend at booth 24147 to learn more about our ongoing clinical trials and engage in scientific exchange with our msls. #mirvetuximab 
We exist to interrupt the progress of cancer so cancer can't interrupt the lives of our patients. #TargetABetterNow

Policy: https://t.co/MLtPQiuFPo